Albion News

This partnership will cover the full domestic programme and Opta will provide fast and accurate ball-by-ball data feeds from all matches.This deal further cements Opta’s place as Europe’s premier sports data suppliers, and complements an extensive international cricket database. ECB Commercial Director John Perera said “Cricket is a sport which thrives on statistical analysis. Our new partnership is designed to boost fans’ interest in the sport as well as providing an important resource for our key stakeholders and media partners. Opta is an established market leader in the field of sports... read more
– Radnor House, new independent day school, rated “Outstanding” by Ofsted. – First new school in the country to receive “Outstanding” judgement in all seven inspection areas. Radnor House School opened on 5th September 2011 with almost 150 pupils and after just 120 teaching days was rated as “Outstanding” by Ofsted in all seven areas of the inspection. This is the first time a new school has received the highest rating of educational success from Ofsted since new legislation was introduced in 2002 read more
We have invested more than £60m across 20 Healthcare companies since 1996 with a strong and consistent track record. read more
Demand in translational science drives need for additional equipment Germantown, MD, 6th February 2012 – XCELERON, a leader in accelerating drug development using ultra-sensitive bioanalytical analyses, today announced that existing investors Albion and Solon Ventures have invested $2.4MM to locate all of the company’s business in its custom-built facility in Germantown, MD which is expected to be fully operational by 31st March 2012. Xceleron is relocating senior analytical staff to Germantown from York, hiring new staff in Maryland and retaining a strong study design and project management... read more
Oxford Diagnostic Laboratories announces the opening of its new, 35,000 square foot, state-of-the-art laboratory located in Memphis, Tennessee. The company celebrated this significant event with a ribbon cutting event that was attended by local and state officials from Tennessee as well as the executive team from Oxford Immunotec. The company expects to invest $3 million and to create 65 new lab processing, medical technologist and management positions at the Memphis facility. Oxford Diagnostic Laboratories is the service laboratory division of Oxford Immunotec, Inc., an immunology-focused... read more
Raises further financing from pool of investors to finance expansion into China and further acquisitions San Diego, USA and Cheltenham, UK – 1st February, 2012. Atego, the world leading software tools and professional services supplier, for complex, mission- and safety-critical systems and software engineering, announced today that it has secured an additional, multi-million dollar equity investment. Existing investor ETV Capital led the funding with participation from Albion, new investor ESO and individual investors. The funds will be used to finance the Atego’s current growth plan... read more
Albion today announces an investment in Hilson Moran Holdings Limited to enable the staff of Hilson Moran Partnership Limited (“Hilson Moran”), an engineering and environmental consultancy, to carry out a £5 million MBO and gain independence from the UK subsidiary of Altran Technologies S.A. Hilson Moran provides consultancy in building services, sustainability, facilities management and other services and is firmly established as a leading engineering consultancy to commercial office, data centre, retail, leisure, hotel and residential projects such as “The Gherkin”, Wembley Arena and the... read more
Mirada Medical announced that it has been selected to deliver its advanced XD3 image review and analysis software to The University of Texas MD Anderson Cancer Center in Houston. Mirada's latest XD3 software release includes volumetric CT segmentation in addition to tools for CT/PET and MR/PET to facilitate both anatomical and functional response tracking. Mirada XD3 provides powerful tools and efficient workflows for quantification and tracking of findings in an unlimited number of studies for all major modalities including CT, MR, CT/PET and MR/PET. "We are delighted that MD Anderson Cancer... read more